VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-7.21 Cr | ₹-51 Cr | ₹-17 Cr | ₹56 Cr | ₹-4.75 Cr |
What is the latest Cash Flow from Investing Activities ratio of VENUS REMEDIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-7.21 Cr |
Mar2023 | ₹-51 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹56 Cr |
Mar2020 | ₹-4.75 Cr |
How is Cash Flow from Investing Activities of VENUS REMEDIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-7.21 Cr | Negative | |
Mar2023 | ₹-51 Cr | Negative | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹56 Cr | Positive | |
Mar2020 | ₹-4.75 Cr | - |
Compare Cash Flow from Investing Activities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹738.3 Cr | 21.5% | 28.3% | 37.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 21.5% |
28.3% |
37.8% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses